Ayşe ÖZDEMİR, Pervin KARLI, Bahattin AVCI

Serum ve foliküler sıvıdaki midkin düzeyleri IVF-ICSI sonuçlarını etkiler mi?

Amaç: Güncel çalışmalar, midkinin (MK) granüloza hücrelerinde apoptozu inhibe ettiğini ve foliküler anjiyogenezden sorumlu olduğunu göstermiştir. Bu çalışmanın amacı, midkin seviyeleri ile ART sonuçları arasındaki ilişkiyi araştırmaktır.Gereç ve Yöntem: Çalışmaya Şubat 2019 ve Nisan 2019 tarihleri arasında Ondokuz Mayıs Üniversitesi’nde IVF-ICSI uygulanan toplam 99 hasta dahil edildi. Çalışmadaki 99 hastanın birinde embriyo gelişimi sağlanamadı ve 14 hastada oosit toplanmasıyla (OPU) oosit elde edilmedi. ve oosit kriyoprezervasyon 17 hastada oluşturuldu. Toplam 67 hastaya IVF-ICSI sonrası taze embriyo transferi yapıldı. OPU gününde serum ve foliküler sıvılardaki midkin seviyesi incelendi. Primer sonuç gebelik, sekonder sonuç blastosist-aşamalı embriyolar olarak belirlendi.Bulgular: Serum ve foliküler sıvıdaki midkin düzeyi gebelerde gebe olmayanlara göre daha yüksek bulundu (p=0,042, p=0,01). Foliküler sıvı ve serumdaki midkin seviyeleri blastokist gelişiminde artışa neden olduğu görülmüştür.Sonuç: Foliküler sıvı ve serumdaki midkin seviyeleri blastokist gelişiminde artışa neden olabilir. Midkin seviyesi gebelerde gebe olmayanlara göre daha yüksek bulunmuştur.

Anahtar Kelimeler:

İn vitro fertilizasyon, gebelik, blastokist, midkin

Do midkine levels in serum and follicular fluid affect IVF-ICSI outcome?

Objective: Current studies have demonstrated that midkine (MK) inhibits the apoptosis in granulosa cells and is responsible for follicular angiogenesis. The aim of this study was to investigate the relation of MK levels and ART outcome.Material and Method: The study included a total of 99 patients who underwent IVF-ICSI at Ondokuz Mayis University between February 2019 and April 2019. Of 99 patients, no embryo development was formed in 1 patient, no oocytes were obtained by oocyte pick up (OPU) in 14 patients and the oocyte cryopreservation was established in 17 patients. In total, 67 patients underwent fresh embryo transfer after IVF-ICSI. On the day of OPU, the level of midkine in serum and follicular fluids were examined. The primary outcome was determined as pregnancy and secondary outcome was determined as blastocyst‐stage embryos. Results: The level of midkine in serum and follicular fluid was found to be higher in pregnant women compared with non-pregnant women (p=0.042 and p=0.01 respectively). Midkine levels in follicular fluid and serum lead to an increase in blastocyst development.Conclusion: Midkine levels in follicular fluid and serum may lead to an increase in blastocyst development. The level of midkine is higher in pregnant subjects than in non-pregnant subjects.

Keywords:

in vitro fertilization, pregnancy, blastocyst, midkine,

PDF

___

1. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem (Tokyo) 2002; 132: 359–71.
2. De Sousa PA, Da Silva SJ, Anderson RA. Neurotrophin signaling in oocyte survival and developmental competence: a paradigm for cellular toti-potency. Cloning Stem Cells 2004; 6: 375–85.
3. Hirota Y, Osuga Y, Nose E, et al. The presence of midkine and its possible implication in human ovarian follicles. Am J Reprod Immunol 2007; 58: 367–73.
4. Ikeda S, Saeki K, Imai H, Yamada M. Abilities of cumulus and granulosa cells to enhance the developmental competence of bovine oocytes during in vitro maturation period are promoted by midkine; a possible implication of its apoptosis suppressing effects. Reproduction 2006; 132: 549–57.
5. Leidenfrost S, Boelhauve M, Reichenbach M, et al. Cell arrest and cell death in mammalian preimplantation development: lessons from the bovine model. Plos ONE 2011; 6: e22121.
6. Li R, Albertini DF. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nat Rev Mol Cell Biol 2013; 14: 141–52.
7. Muramatsu H, Zou P, Kurosawa N, et al. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells 2006; 11: 1405–17.
8. Ikeda S, Ichihara-Tanaka K, Azuma T, Muramatsu T, Yamada M. Effects of midkine during in vitro maturation of bovine oocytes on subsequent developmental competence. Biol Reprod 2000; 63: 1067–74.
9. Hirota Y, Osuga Y, Koga K, et al. Possible implication of midkine in the development of endometriosis. Hum Reprod 2005; 20: 1084–9.
10. Ohyama Y, Miyamoto K, Minamino N, Matsuo H. Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol Cell Endocrinol 1994; 105: 203–8.
11. Karino S, Minegishi T, Ohyama Y, et al. Regulation and localization of midkine in rat ovary. FEBS Lett 1995; 362: 147–50.
12. Brevini-Gandolfi, T. A. L., and F. Gandolfi. The maternal legacyto the embryo:cytoplasmic components and their effects on earlydevelopment. Theriogenology 2001; 55: 1255–76.
13. Sirard MA, Richard F, Blondin P, Robert C. Contribu-tion of the oocyte to embryo quality. Theriogenology 2006; 65: 126–36.
14. Krisher RL. The effect of oocyte quality on development. J Anim Sci 2004; 82 (Suppl. E): E14–E23.
15. Kupker W, Diedrich K, Edwards RG. Principles of mammalian fertilization. Hum Reprod 1998; 13 (Suppl 1): 20–32.
16. Ikeda S, Azuma T, Hashimoto S, Yamada M. In vitro maturation of bovine oocytes with fractions of bovine follicular fluid separated by heparin affinity chromatography. J Reprod Dev 1999; 45: 397–404.
17. Seli E, Zeyneloglu HB, Senturk LM, Bahtiyar OM, Olive DL, Arici A. Basic fibroblast growth factor: peritoneal and follicular fluid levels and its effect on early embryonic development. Fertil Steril 1998; 69: 1145–8.
18. Ohyama Y, Miyamoto K, Minamino N, Matsuo H. Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol Cell Endocrinol 1994; 105: 203–8.
19. Chung HW, Wen Y, Choi EA, et al. Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. Mol Hum Reprod 2002; 8: 350–5.